Model
Edge
Galectin Therapeutics Inc
0001827180
Filing Type
4
Filing Date
4/3/2022
Updated
4/4/22, 8:58 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership